Advertisement

How to get the most out of treatment for spms

How to get the most out of treatment for SPMS

Updated on December 8, 2025

Multiple sclerosis (MS) is an autoimmune disorder where the immune system causes inflammation and damage in the central nervous system. Most people with MS are initially diagnosed with relapsing-remitting MS, which is characterized by episodes of worsening symptoms (relapses) followed by periods where symptoms improve (remissions).

Most people with RRMS will eventually develop secondary progressive multiple sclerosis (SPMS). This is a secondary phase of the disease where symptoms gradually become more severe, without remissions.

Are there medications that treat SPMS?

Treatment will depend on whether SPMS is relapsing or non-relapsing. Relapsing SPMS involves relapses similar to RRMS, but there is also a gradual progression of symptoms between relapses.

Non-relapsing SPMS does not involve relapses. Symptoms gradually worsen and disability gradually accumulates. Changes and symptoms can be difficult to identify without distinct relapses.

Disease-modifying therapies

Disease-modifying therapies (DMTs) are drugs that help reduce disease activity and slow the progression of MS. There are several DMTs available for the treatment of relapsing SPMS.

Treatment options for non-relapsing SPMS are limited. The first disease-modifying therapy for this category of SPMS is expected to become available in early 2026. This medication is a BTK inhibitor, a drug that blocks the activity of Bruton’s tyrosine kinase (BTK) enzyme. Blocking this enzyme helps regulate the activity of immune cells linked to MS inflammation and progression.

Other new and emerging therapies may be available through clinical trials. New and emerging therapies are an important topic to discuss with a healthcare team, especially if current treatment options are limited.

Medications to manage symptoms

In addition to DMTs, treatment often involves other medications to reduce and manage specific symptoms. While these medications do not affect the progression of SPMS, they can help improve a person’s quality of life while living with SPMS. This can include medications to help with pain, bladder control, fatigue, and mood disorders.

Like other parts of a treatment plan, this will vary from person to person.

How can I get the most from SPMS treatment?

The number one thing you can do to get the most out of treatment is to follow your treatment plan as closely as possible. This means taking your medication exactly as prescribed. It also means attending every scheduled appointment—regular monitoring through MRI scans and neurological exams are essential to managing SPMS.

Communication

Be honest with your healthcare team and be proactive about sharing information. This includes concerns, unmet treatment needs, cognitive changes, sleep, changes in symptoms, and any difficulty following a treatment plan.

Supportive therapies

SPMS can affect mobility, functioning, communication, and speech. Physical therapists, occupational therapists, and speech therapists can all play important roles. Cognitive rehabilitation may help if SPMS is affecting thinking and memory.

Primary care

Regular appointments with a primary care provider can help you manage other areas of your health and monitor for common health conditions, such as cardiovascular disease, diabetes, and osteoporosis.

Mental health

Talk to your healthcare provider about how you're coping emotionally. Depression and anxiety are common among people with MS. Counselors, mental health professionals, religious and spiritual advisors, and support groups can be valuable parts of a treatment plan.

Keep a symptom journal

Keeping a daily record of how you feel can help you identify gradual changes in symptoms and make it easier to share this information with your healthcare provider. A journal can also help you prepare for your appointments, keep track of what you want to discuss with your providers, and identify what you need from treatment.

Article sources open article sources

National Institute of Neurological Disorders and Stroke. What is multiple sclerosis?. Accessed November 25, 2025.
Dawood Tafti, Moavia Ehsan, and Kathryn L. Xixis. Multiple Sclerosis. StatPearls. March 20, 2024.
Vijayalakshmi Vasanthaprasad, Vivek Khurana, et al. Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil. BMC Neurology, 2022. Vol. 22, No. 201.
MS Society. Secondary progressive MS (SPMS). Accessed November 25, 2025.
Cleveland Clinic. Secondary Progressive Multiple Sclerosis (SPMS). Accessed November 25, 2025.
Tjalf Ziemssen, Chloe Tolley, et al. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians’ and patients’ views. Multiple Sclerosis and Related Disorders, 2020. Vol. 38.
National Multiple Sclerosis Society. FDA Extends Its Review of Tolebrutinib for Non-Relapsing Secondary Progressive MS. September 22, 2025.
ScienceDirect. Bruton Tyrosine Kinase. Accessed November 25, 2025.
National Multiple Sclerosis Society. Results Announced of “BTK Inhibitor” Tolebrutinib: Delays Time to Disease Progression in Secondary Progressive MS, Does Not Meet Primary Endpoint in Relapsing MS Studies. September 3, 2024.
MS Trust. Drugs in Development. Accessed November 25, 2025.
National Multiple Sclerosis Society. Secondary Progressive Multiple Sclerosis (SPMS). Accessed November 25, 2025.
National Multiple Sclerosis Society. National Multiple Sclerosis Society. Accessed November 25, 2025.
Behnam Golabi, Hadis Razmaray, et al. Sleep and cognitive outcomes in multiple sclerosis; a systematic review. BMC Psychiatry. September 28, 2024.
Brooke Dulka. How Does Cognitive Rehabilitation for MS Work? 4 Ways It Can Help. MyMSTeam. January 18, 2023.
National Multiple Sclerosis Society. Make the Most of Your Healthcare Provider Visits. Accessed November 25, 2025.
Cleveland Clinic. Behavioral Management of Anxiety and Depression in Multiple Sclerosis. Accessed November 25, 2025.

Featured Content

article

5 strategies to advocate for yourself during SPMS treatment

These strategies can help you take an active role in treatment for secondary progressive multiple sclerosis (SPMS).
article

Secondary progressive MS: Building your support network

A support network can help you prepare for the mental, emotional, and practical challenges of navigating SPMS.